Denali Therapeutics DNLI
Denali Therapeutics Inc. hosted its 2025 Investor Day, during
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001714899-25-000209
- Makes a Regulation FD disclosure (7.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Spyre Therapeutics SYRE public float $1.1B, Jun 30, 2025
- Schrodinger SDGR public float $1.1B, Jun 30, 2025
- Mannkind MNKD public float $1.1B, Jun 30, 2025
- Novavax NVAX public float $1.0B, Jun 30, 2025
- Harrow HROW public float $1.0B, Jun 30, 2025
